Cil, T.
82  results:
Search for persons X
?
2

181P SELECT: A phase II randomized trial evaluating 2 doses..:

Gumus, M. ; Sukalinskaya, A. ; Andric, Z.G....
Immuno-Oncology and Technology.  16 (2022)  - p. 100293 , 2022
 
?
5

Psychosocial outcomes following contralateral prophylactic ..:

Lim, D. ; Retrouvey, H. ; Kerrebijn, I....
European Journal of Cancer.  138 (2020)  - p. S44-S45 , 2020
 
?
6

Predictors of Survival and Patterns of Recurrence in Breast..:

Keilty, D. ; Namini, S. Nezafat ; Swain, M....
International Journal of Radiation Oncology*Biology*Physics.  105 (2019)  1 - p. E24-E25 , 2019
 
?
7

Pertuzumab, trastuzumab and taxane-based treatment for visc..:

Turkish Oncology Group ; Esin, Ece ; Oksuzoglu, B....
Cancer Chemotherapy and Pharmacology.  83 (2018)  1 - p. 131-143 , 2018
 
?
9

An International Multicenter Review of the Malignancy Rate ..:

Foley, N. M. ; Racz, J. M. ; Al-Hilli, Z....
Annals of Surgical Oncology.  22 (2015)  S3 - p. 385-390 , 2015
 
?
10

PATI: Patient accessed tailored information:

Foley, N. M. ; Connolly, G. ; Tabirca, S....
Annals of Medicine & Surgery.  3 (2014)  2 - p. 48 , 2014
 
?
11

How to Increase the Diagnostic Value of Malignancy-Related ..:

Tuzun, Y ; Yilmaz, Ş ; Dursun, M...
Journal of International Medical Research.  37 (2009)  1 - p. 87-95 , 2009
 
?
13

Factors Affecting Axillary Lymph Node Retrieval and Assessm..:

Cil, T. ; Hauspy, J. ; Kahn, H....
Annals of Surgical Oncology.  15 (2008)  12 - p. 3361-3368 , 2008
 
?
14

1233 POSTER Hepatitis B and C viruses seroprevalence of can..:

Cil, T. ; Altintas, A. ; Pasa, S...
European Journal of Cancer Supplements.  5 (2007)  4 - p. 170 , 2007
 
?
15

A simple way to estimate mean plasma glucose and to identif..:

Ozmen, S. ; Cil, T ; Atay, A. E...
Diabetic Medicine.  23 (2006)  10 - p. 1151-1154 , 2006
 
1-15